Navigating the Biotech Landscape: PhasAGE Workshop Connects Innovators, Investors, and Researchers to Foster Funding for Biotech Start-ups


The III PhasAGE International Conference, which took place at i3S from 18 to 20 October 2023, kicked off with a half-day pre-event workshop dedicated to biotech and the valorisation of research and development in academia. 

The event started with some welcoming words from Sandra Ribeiro, the PhasAGE project coordinator, followed by a short note from Peter Tompa, a core researcher from VIB, and one of the partners of the PhasAGE consortium. 

Peter shared his own pathway moving from academia to set up a biotech start-up company. He also shared the importance of preparing a good pitch presentation for securing biotech start-up funding from private investors.

Welcome from Sandra Ribeiro, PhasAGE coordinator
Peter Tompa sharing tips on how to pitch your ideas

The program also featured short presentations from three researchers heading early-stage start-ups from the University of Porto. They received important insights and tips from Peter Tompa and Anke Caβing, principal from a venture capital investor firm and member of the PhasAGE scientific advisory board. 

Participants at the Biotech Workshop

Bringing together scientific experts, biotech owners/representatives and research investors is a promising strategy to level up the translation and valorisation of research in academia. These round-table discussions aspire to shorten the gap between R&D carried out at Universities/Research Institutes and Industry, fostering an optimal collaborative atmosphere for generating novel ideas and tackling fresh challenges.

This event was co-organized by Pedro Martins, senior researcher and PhasAGE member and Hugo Prazeres, head of the Knowledge Transfer Office at i3S.